Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

S Narula, S Yusuf, M Chong, C Ramasundarahettige… - The Lancet, 2020 - thelancet.com
Background Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator
of the renin–angiotensin hormonal cascade. We assessed whether plasma ACE2 …

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.

S Narula, S Yusuf, M Chong… - Lancet (London …, 2020 - europepmc.org
Background Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator
of the renin-angiotensin hormonal cascade. We assessed whether plasma ACE2 …

[引用][C] Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

S Narula, S Yusuf, M Chong, C Ramasundarahettige… - The Lancet, 2020 - cir.nii.ac.jp

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.

S Narula, S Yusuf, M Chong, C Ramasundarahettige… - 2020 - cabidigitallibrary.org
Abstract Background: Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-
regulator of the renin-angiotensin hormonal cascade. We assessed whether plasma ACE2 …

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

S Narula, S Yusuf, M Chong… - Lancet (London …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator
of the renin-angiotensin hormonal cascade. We assessed whether plasma ACE2 …

Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

S Narula, S Yusuf, M Chong, C Ramasundarahettige… - The Lancet, 2020 - Elsevier
Background Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator
of the renin–angiotensin hormonal cascade. We assessed whether plasma ACE2 …

[HTML][HTML] Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis

S Narula, S Yusuf, M Chong… - Lancet (London …, 2020 - ncbi.nlm.nih.gov
Background Angiotensin-converting enzyme 2 (ACE2) is an endogenous counter-regulator
of the renin–angiotensin hormonal cascade. We assessed whether plasma ACE2 …